Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4216 AL 4230

Editorial: Unraveling the gut's role in levodopa metabolism-promise and uncertainties of fecal tdc in Parkinson's disease

Zhang L.

Parkinsonism Relat Disord. 2025 Sep;138:107977. doi: 10.1016/j.parkreldis.2025.107977. Epub 2025 Jul 28.

Corrigendum to "Shared pathogenic mechanisms of Parkinson's disease and ulcerative colitis: α7 nicotinic acetylcholine receptor as a potential therapeutic target" [Int. J. Biol. Macromol. 2025 Jul 1; 319(Pt 4):145701]

Li Y, Gu Y, Li J, Liu F, Chen H, Hou H, Hu Q.

Int J Biol Macromol. 2025 Sep;322(Pt 1):146651. doi: 10.1016/j.ijbiomac.2025.146651. Epub 2025 Aug 13.

Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials

Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group.

NPJ Parkinsons Dis. 2025 Aug 13;11(1):241. doi: 10.1038/s41531-025-01103-y.

Beyond the gut: decoding the gut-immune-brain axis in health and disease

Park JC, Chang L, Kwon HK, Im SH.

Cell Mol Immunol. 2025 Nov;22(11):1287-1312. doi: 10.1038/s41423-025-01333-3. Epub 2025 Aug 14.

Effects of Virtual Reality Based on Fall Prevention Intervention: A Systematic Review and Meta-Analysis

Park BM, Choi H, Jeong H.

Healthcare (Basel). 2025 Jul 29;13(15):1845. doi: 10.3390/healthcare13151845.

The Cognitive Cost of Motor Control: A Systematic Review and Meta-Analysis of Parkinson's Disease Treatments and Financial Decision-Making

Kandylaki N, Patrikelis P, Konitsiotis S, Messinis L, Folia V.

Healthcare (Basel). 2025 Jul 29;13(15):1850. doi: 10.3390/healthcare13151850.

Healthcare Complexities in Neurodegenerative Proteinopathies: A Narrative Review

Fereshtehnejad SM, Lökk J.

Healthcare (Basel). 2025 Jul 31;13(15):1873. doi: 10.3390/healthcare13151873.

TREM2 in Neurodegenerative Disorders: Mutation Spectrum, Pathophysiology, and Therapeutic Targeting

Yang H, Kim D, Yang Y, Bagyinszky E, An SSA.

Int J Mol Sci. 2025 Jul 22;26(15):7057. doi: 10.3390/ijms26157057.

Neuroprotective Roles of Vitamin D: Bridging the Gap Between Mechanisms and Clinical Applications in Cognitive Decline

Liu Y, Zhong Z, Xie J, Ni B, Wu Y.

Int J Mol Sci. 2025 Jul 24;26(15):7146. doi: 10.3390/ijms26157146.

Microtubule-Targeting Agents: Advances in Tubulin Binding and Small Molecule Therapy for Gliomas and Neurodegenerative Diseases

Ezzo M, Etienne-Manneville S.

Int J Mol Sci. 2025 Aug 7;26(15):7652. doi: 10.3390/ijms26157652.

A Comprehensive Review of a Mechanism-Based Ventricular Electrical Storm Management

Negru AG, Iovanovici DC, Lascu A, Pescariu AS, Cismaru G, Crișan S, Ailoaei Ș, Bebec DL, Streian CG, Bîrza MR, Manzur AR, Luca SA, David D, Moșteoru S, Gaiță D, Luca CT.

J Clin Med. 2025 Jul 29;14(15):5351. doi: 10.3390/jcm14155351.

The Effectiveness of Virtual Reality in Improving Balance and Gait in People with Parkinson's Disease: A Systematic Review

Fernandes S, Oliveira B, Sacadura S, Rakasi C, Furtado I, Figueiredo JP, Gonçalves RS, Martins AC.

Sensors (Basel). 2025 Aug 4;25(15):4795. doi: 10.3390/s25154795.

Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives

Aktaş E, Hanağası HA, Özgentürk NÖ.

CNS Neurosci Ther. 2025 Aug;31(8):e70540. doi: 10.1111/cns.70540.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias